Sub-Therapeutic Concentrations of Hexetidine Induce Virulence Gene Expression in Candida albicans

These results give an idea of future strategies for developing and using HEX as an adjunctive therapy for oral candidiasis. The innovation and clinical relevance of our research lie in its exploration of how low doses of HEX influence gene expression over varying time periods, potentially paving the way for alternative therapeutic strategies.